Latest Sustainable Growth News

Mach7 Technologies has updated its FY25 guidance, reporting positive cash flow and a solid financial position, while appointing Teri Thomas as its new CEO to steer the company’s next growth phase.

De.mem Limited has reported its second highest quarterly cash receipts ever, alongside a fourth consecutive quarter of positive operating cash flow, positioning the company for a record full-year 2025 performance.

Advanced Braking Technology Ltd (ABT) posted a robust FY25 with sales up 27% and underlying profits nearly doubling, driven by strong international demand and innovation milestones.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Buru Energy advances its Rafael Gas Project in Western Australia with a focus on sustainable growth, targeting a final investment decision in 2026 and production start in 2028. The project aims to supply local power generation with trucked LNG and condensate, replacing costly imports.

Ramelius Resources delivered record FY25 gold production and free cash flow, surpassing guidance, while finalising its transformative acquisition of Spartan Resources. The company is ramping up exploration and integration efforts to target half a million ounces annual production by FY30.

ikeGPS reports a robust 29% increase in annual platform subscription revenue exit run rate for 1Q FY26, reiterating strong FY26 growth guidance and securing A$18 million in fresh capital to fuel expansion and new product development.

Kaiser Reef has completed a transformative acquisition of the Henty Gold Mine, backed by a $20.9 million capital raise, positioning the company for significant growth in Tasmania and Victoria.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.

Compumedics has secured two significant four-year distribution agreements in China worth A$24.4 million, reinforcing its strategic foothold in Asia with committed annual growth of at least 10%.

Raiz Invest Limited reported robust growth in Q4 FY25, with active customers and funds under management hitting new highs, supported by a strategic partnership with Drip Invest and ongoing product innovation.